-
Product Insights
Colmac Biomass Power Plant
Colmac Biomass Power Plant is a biopower project located in California, United States. The project is owned by Greenleaf Power LLC and was developed by ACI Energy Inc. The project came online in 1992. Empower your strategies with our Colmac Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Pecineaga Wind Farm
Pecineaga Wind Farm is an Onshore Wind project located in Constanta, Romania. The project is owned by Eurowind Energy AS and is developed by ACI (Pvt) Ltd; Eurowind Energy AS. The project is currently under construction. Empower your strategies with our Pecineaga Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Citarinostat in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Citarinostat in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Citarinostat in Relapsed Multiple Myeloma Drug Details: Citarinostat (ACY-241) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Citarinostat in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Citarinostat in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Citarinostat in Melanoma Drug Details: Citarinostat (ACY-241) is under development for the treatment...
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Citarinostat in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Citarinostat in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Citarinostat in Non-Small Cell Lung Cancer Drug Details: Citarinostat (ACY-241)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Citarinostat in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Citarinostat in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Citarinostat in Refractory Multiple Myeloma Drug Details: Citarinostat (ACY-241) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Citarinostat in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Citarinostat in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Citarinostat in Multiple Myeloma (Kahler Disease) Drug Details: Citarinostat...
-
Product Insights
Net Present Value Model: Cerevel Therapeutics Holdings Inc’s Tavapadon
Empower your strategies with our Net Present Value Model: Cerevel Therapeutics Holdings Inc's Tavapadon report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ricolinostat in Charcot-Marie-Tooth Disease Type II
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ricolinostat in Charcot-Marie-Tooth Disease Type II Drug Details: Ricolinostat (ACY-1215) is under development for the...